1Merino R,Hurle J M.The molecular bassis of retinoid action in tumors[J].Trends Molmed,2003,9(12):509 -511.
2Zouboblis CC.Retinoids which dermatological indications will benefit in the near future[J].Skin pharmacol Appl skin Pharmacol,2001,14(5):303 - 15.
3Green L.Sadoff W.A Clinicsl evaluation of tazarotene 0.1% gel,with and without a highor mid high potency corticowteroid,in patients with stable plaquepsoriasis[J].J.Cutan Med Surg,2002,6(2):95 - 102.
4Tan HH.Topical antibacterial treatments for acne vulgaris:comparative review and guide to selection[J].Am J Clin Dermatol,2004,5(2):79-84.
5Gupta AK,Lynde CW,Kunynetz RA,et al.A randomized,doubleblind,multicenter,paralld group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face[J].J Cutan Med Surg,2003,7(1):31-37.
6Smit JV, De Sevaux RG, Blokx WA, et al. Acitretin treatment in(pre)malignant skin disorders of renal transplant recipients:Histologic and immunohistochemical effects[J].J Am Acad Dermatol, 2004, 50 (2): 189-196.
